Abstract
94
Data have been deposited at NCBI's Sequence-Read Archive (SRA) under accession number 95 PRJNA286872. MLST was determined directly from short reads using SRST2 (24). Ambiguous or novel 96 alleles were confirmed by PCR and Sanger sequencing using previously described primers and conditions 97 described in the GBS MLST scheme (25). Novel sequence types have been submitted to PubMLST.
98
Neighbor-joining phylogenetic trees (1,000 bootstrap replications) were generated with SplitsTree4 (26) 99 using the concatenated sequences of the seven loci used in the GBS MLST scheme. Illumina short-reads 100 were then aligned to the genomes of reference strains NGBS061 (serotype IV, GenBank accession 101 number CP007631.2) and SGBS001 (serotype V, ST1, GenBank accession number CP010867) using 7 trees (1,000 bootstrap replications) were generated from the multiFASTA files using SplitsTree4. For 113 comparative purposes, the genome sequences of 76 previously characterized ST1 strains from Toronto 114 (27) and 3 previously characterized ST459 strains from France and the Czech Republic (31), were 115 downloaded from SRA. SRA accession numbers for these isolates are provided in Table S2 
126

Results
127
High prevalence of serotype IV strains among adult invasive GBS disease in Manitoba and
128
Saskatchewan. We first serotyped all 549 strains recovered from adult GBS invasive infections in frequency of isolation of serotype IV GBS strains was relatively constant during each of the five years 135 studied, the overall serotype IV GBS prevalence in Manitoba and Saskatchewan is higher than that 136 previously reported elsewhere in North America (2, 4, 11, 18) and greatly exceeds the 6% prevalence 137 recently reported in Toronto, Ontario, over a time period (2010) (2011) (2012) 
167
The population structure of ST459 isolates suggests clonal expansion. Recently, we described that 168 clonal ST459 GBS strains were responsible for more than 50% of serotype IV GBS invasive disease in 
280
In summary, we describe here the emergence of serotype IV among cases of invasive GBS disease in 281 adults. We demonstrate that, for the most part, this emergence is driven by the expansion of a single 282 ST459 clone that caused dozens of infections over a four year period in Manitoba and Saskatchewan.
283
The clone is resistant to tetracycline, macrolides and lincosamides, and strains show limited genetic IX  VIII  VII  VI  V  IV  III  II  Ib  Ia  NT  IX  VIII  VII  VI  V  IV  III 
